Francisco D. Salva - 18 Mar 2026 Form 4 Insider Report for Azitra, Inc. (AZTR)

Reporting relationship: President and CEO, Director
Issuer ticker: AZTR
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Mar 2026, 16:30:30 UTC
Prior SEC filing: 22 Dec 2025
Next SEC filing: 22 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Francisco D. Salva

Key filing fact

Francisco D. Salva filed Form 4 for Azitra, Inc. (AZTR) on 20 Mar 2026.

Key facts

This page summarizes Francisco D. Salva's Form 4 filing for Azitra, Inc. (AZTR).
3 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 20 Mar 2026, 16:30.

Change

Previous filing in this sequence was filed on 22 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001834051 Primary reporting owner

Salva Francisco D.

Relationship: President and CEO, Director
Address: 21 BUSINESS PARK DRIVE, BRANFORD
Signature: /s/ Francisco D. Salva
Signature date: 20 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AZTR transaction Derivative

Series A Convertible Non-Redeemable Preferred Stock

Purchase

Transaction value
Shares: +500
Change %
Price
Shares after: 500
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,064,050
Exercise price: $0.1230
Footnotes: F1

AZTR transaction Derivative

Series B Warrants

Purchase

Transaction value
Shares: +4,064,050
Change %
Price
Shares after: 4,064,050
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,064,050
Exercise price: $0.1230
Footnotes: F1, F2

AZTR transaction Derivative

Series C Warrants

Purchase

Transaction value
Shares: +4,064,050
Change %
Price
Shares after: 4,064,050
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,064,050
Exercise price: $0.1230
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Series A Preferred Stock has stated value of $1,000.00 per share. Each share of Series A Preferred Stock automatically converts into 8,128.1 shares of Common Stock, subject to adjustment from time to time in accordance with its Certificate of Designations, Preferences, as of 5:00 p.m. Eastern time on the 1st business day after the date that the Issuer's stockholders have approved each of (A) an increase in the number of authorized shares of the Issuer's Common Stock to enable the Issuer to issue all of the shares of Common Stock that are issuable upon the conversion of the Series A Preferred Stock and (B) the conversion of the Series A Preferred Stock into Common Stock in accordance with the listing rules of the applicable trading market, and subject to the Issuer filing an amendment to the Certificate of Incorporation with the Secretary of State of the State of Delaware evidencing such stockholder approval. The Series A Preferred Stock has no expiration date.

Footnote F2

The Series B Warrants are exercisable upon stockholder approval and will terminate 18 months following the date of stockholder approval.

Footnote F3

The Series C Warrants are exercisable upon stockholder approval and will terminate, subject to certain exceptions, upon the 30th calendar day following the date on which Azitra, Inc. publicly announces data from its planned human cosmetic study testing the effect of the filaggrin technology.